Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

CPI-360 (CAS 1802175-06-9)

0.0(0)
Write a reviewAsk a question

Datasheets
Alternate Names:
N-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-2-methyl-1-[(1R)-1-(tetrahydro-2H-pyran-4-yl)ethyl]-1H-indole-3-carboxamide
CAS Number:
1802175-06-9
Molecular Weight:
437.5
Molecular Formula:
C25H31N3O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

QUICK LINKS


CPI-360 (CAS 1802175-06-9) References

  1. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.  |  Bayo, J., et al. 2015. Future Med Chem. 7: 2243-61. PMID: 26510529
  2. Inhibitors of protein methyltransferases as chemical tools.  |  Luo, M. 2015. Epigenomics. 7: 1327-38. PMID: 26646500
  3. An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition.  |  Egan, B., et al. 2016. PLoS One. 11: e0166438. PMID: 27875550
  4. 18F-Labeled PET Probe Targeting Enhancer of Zeste Homologue 2 (EZH2) for Cancer Imaging.  |  Yu, L., et al. 2019. ACS Med Chem Lett. 10: 334-340. PMID: 30891136
  5. Development of molecular intervention strategies for B-cell lymphoma.  |  Zhou, W. and Chen, W. 2021. Expert Rev Hematol. 14: 241-252. PMID: 33263441
  6. Altered pathways and targeted therapy in double hit lymphoma.  |  Zhuang, Y., et al. 2022. J Hematol Oncol. 15: 26. PMID: 35303910
  7. Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors.  |  Shinohara, H., et al. 2022. Mol Ther Oncolytics. 27: 14-25. PMID: 36212776
  8. Derepressing of STAT3 and USP7 contributes to resistance of DLBCL to EZH2 inhibition.  |  He, C., et al. 2023. Heliyon. 9: e20650. PMID: 37829803
  9. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models.  |  Miao, T., et al. 2024. Int J Mol Sci. 25: PMID: 38279262
  10. EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy.  |  Visamol, S., et al. 2024. Sci Rep. 14: 7947. PMID: 38575707

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

CPI-360, 1 mg

sc-507464
1 mg
$100.00